Table 2 Characteristics of radiologic imaging and pathology in patients with IPMN with/without AP
| Â | IPMN | P-value | |
|---|---|---|---|
AP (n = 11) | Non-AP (n = 36) | ||
Radiologic imaging | Â | Â | Â |
 IPMN Site |  |  | 1.000 |
  Body and tail | 2 (18.2) | 6 (16.7) |  |
  Head and neck | 9 (81.8) | 30 (83.3) |  |
 IPMN type |  |  | 0.785 |
  MD | 1 (9.1) | 4 (11.1) |  |
  MIX | 3 (27.3) | 14 (38.9) |  |
  BD | 7 (63.6) | 18 (50.0) |  |
 MPD |  |  | 0.435 |
  < 10 mm | 7 (63.6) | 28 (77.8) |  |
  ≥ 10 mm | 4 (36.4) | 8 (22.2) |  |
 Cystic |  |  |  |
  < 30 mm | 7 (63.6) | 13 (38.2) | 0.176 |
  ≥ 30 mm | 4 (36.4) | 21 (61.8) |  |
  missing | 0 | 2 |  |
 Tuberous enhancement | 3 (27.3) | 8 (22.2) | 0.703 |
 Cystic wall enhancement | 3 (27.3) | 13 (36.1) | 0.725 |
 Calcification | 3 (27.3) | 4 (11.1) | 0.330 |
Pathology | Â | Â | Â |
 Epithelial subtype |  |  | 0.494 |
  Gastric | 0 (0) | 6 (21.4) |  |
  Intestinal | 3 (42.9) | 6 (21.4) |  |
  Pancreatobiliary | 3 (42.9) | 13 (46.4) |  |
  Oncocytic | 1 (14.3) | 3 (10.7) |  |
  Unknown | 4 | 8 |  |
 Degree of dysplasia |  |  | 0.213 |
  LGD | 2 (18.2) | 11 (30.6) |  |
  MGD | 3 (27.3) | 14 (38.9) |  |
  HGD | 4 (36.4) | 3 (8.3) |  |
  IC | 2 (18.2) | 8 (22.2) |  |
 Chronic pancreatitis | 3 (27.3) | 14 (38.9) | 0.722 |
 Glandular atrophy | 2 (18.2) | 8 (22.2) | 1.000 |